Anvisa, Government agency

The Brazil National Health Surveillance Agency (Anvisa) declined the request to approve the Russian-developed Sputnik V vaccine against COVID-19 for emergency use in Brazil.Citing the agency, TASS reported that the request does not comply with the minimal criteria for this task."The request was returned to Uniao Quimica, because it does not comply with the minimal criteria in particular, due to lack of permission for third phase of clinical trials, as well as in regards to issue dealing with the advanced production methods," TASS quoted the vsa.This comes after, Uniao Quimica, a partner of the Russian Direct Investment Fund (RDIF), contacted Anvisa, last year in the month of December, requesting permission to conduct the third stage of clinical trials for the Sputnik V vaccine in Brazil.vsa stated that, considering previous experience of reviewing such applications, the decision could have been provided within 72 hours. However, later, the agency requested additional information on the vaccine.On Friday, Uniao Quimica and the Russian Fund filed a request for emergency use of 10 million doses of the Sputnik V in Brazil."Uniao Quimica believes that, in response to the COVID-19 pandemic escalation in Brazil and the rest of the world, the state and the business must take all efforts to fight it, including by taking measures of emergency and exceptional nature, justified by the urgent need and the importance of the current moment," TASS quoted the company statement.According to TASS, in January, Uniao Quimica received cellular material for production of the vaccine.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

AnvisaFOLLOW

Anvisa, Latest News

Health :Brazil reports first cases of Omicron variant

Rio De Janeiro, Dec 1 Brazil became the first Latin American country to report cases of the Omicron ... ...

International :Senior officials of Brazilian Health Regulator face threats over vaccination of children

The senior management of the Brazilian Health Regulatory Agency, Anvisa, has received death threats over the possible approval of COVID-19 vaccination for children, the agency said. ...

International :Brazil approves proposal to import Bharat Biotech's Covaxin with regulation

Brazil has approved the import of Bharat Biotech manufactured COVID-19 vaccine Covaxin into the country with regulations, informed ANVISA on Friday. ...

International :Brazil's health regulator authorises use of AstraZeneca, Sinovac vaccines against COVID-19

The Brazilian Health Regulatory Agency (Anvisa) on Sunday approved the use of two vaccines against the coronavirus disease, developed by companies AstraZeneca and Sinovac. ...

International :Brazilian health regulator declines emergency use of Sputnik V vaccine

The Brazil National Health Surveillance Agency (Anvisa) declined the request to approve the Russian-developed Sputnik V vaccine against COVID-19 for emergency use in Brazil. ...